Skip to main content

Shunichi Yamashita's Graph Alteration

At the Annual Meeting of the National Council on Radiation Protection & Measurements (NCRP) held in Bethesda, Maryland, on March 11, 2013, Shunichi Yamashita, the Radiation Risk Management Advisor for Fukushima Prefecture and then vice president of Fukushima Medical University, gave a keynote address.

Yamashita's keynote address video
Yamashita's keynote address PowerPoint presentation PDF

His PowerPoint presentation included a version of a graph from the 2005 study by Cardis et al., Risk of Thyroid Cancer After Exposure to 131I in Childhood, linked here Yamashita was one of the co-authors of the study, and the graph he referred to is "Fig. 2 Comparison of odds ratios (ORs) predicted by the best-fitting risk models with categorical odds ratios estimated in 11 dose categories," on page 729.

On page 727 of the Cardis study, it is stated:
"Figure 2 shows the variation in odds ratios as a function of dose level. A strong dose-response relationship was observed (P<.001); the odds ratio appeared to increase linearly with dose up to 1.5-2 Gy and then to plateau at higher doses. Statistically significant increases in risk were associated with all radiation dose categories greater than 0.2 Gy.
The statistical models that best describe these data are the linear excess relative risk model up to 1 Gy, the linear excess relative risk model up to 2 Gy, and the linear-quadratic excess relative risk model over the entire dose range. As shown in Fig. 2, however, the latter model tended to underestimate risks up to 2 Gy. "

Here's Yamashita's version, which is slide 12 of his PowerPoint presentation titled "Risk of Childhood Thyroid Cancer around Chernobyl."


Here's the original Cardis version:


It appears that he omitted the curve 1, the ERR model - linear-quadratic dose-response model over the entire dose range, which was considered one of the best-fit models. Is it because it "tended to underestimate risks up to 2 Gy"?

The videotape of Yamashita's keynote address revealed the following statement (sic) associated with this slide:
"According to other joint project on the case control studies, it's also clearly shown the increase of thyroid cancer by in dose-responsibly by radioactive iodine.   These data also reconfirmed by United States and Belarus and United States-Ukranian cohort project recently. This is really important to understand the dose-responsiveness of how much they received thyroid dosing."

Apparently he used the slide to show the dose-response of thyroid cancer risk.

Alfred Korblein, a physicist from Germany who has analyzed post-Chernobyl and post-Fukushima birth and mortality data, plotted the data points from Yamashita's graph as well as the original Cardis version, as shown below.


A question remains unanswered as to the reason behind Yamashita's decision to leave out the curve 1. In addition, a question arises as to if it's appropriate for him to cite the original study, as he did in the slide, when the graph has been "altered" by him.

Is this ethical as a researcher?

A consensus by a group of international researchers was that it probably wasn't. Cardis was contacted with the above information multiple times, but she never responded.

When asked what he thought of Yamashita's action of making his own graph yet citing the Cardis study as a source, Korblein said, "I would call it deception or fraud."



Popular posts from this blog

"Strict" Management of the Fukushima Health Management Survey Data by Fukushima Medical University

The Interim Report released in March 2016 by the Oversight Committee for Fukushima Health Management Survey called for the need to establish the rules of management and provision of the data so it can be widely utilized by domestic and international experts. Accordingly, the Subcommittee to Review Provision of Data for the Purpose of Academic Research met in Fukushima City, Fukushima, for the first time on May 31, 2016. Subcommittee members were selected by the Fukushima prefectural government in order to address the role of the subcommittee in establishing technical rules in provision of data and include specialists in epidemiology, information technology, law, and legal sociology. Also included are members of the Oversight Committee for Fukushima Health Management Survey, Shoichiro Tsugane and Hokuto Hoshi, and the Health Survey Support Department Head and the Department of Epidemiology Chair at Fukushima Medical University, Tetsuya Ohira, representing the Fukushima Health Managemen…

A Letter Hand-delivered to the UN and UNSCEAR, Requesting Revision of UNSCEAR Report And a New UN Mandate for UNSCEAR

On October 24, 2014, at the Fourth Committee of the UN General Assembly being held in New York City, representatives from Physicians for Social Responsibility (USA) and Human Rights Now (Tokyo, Japan) hand-delivered a letter to the chairperson of the 4th Committee and the Secretary of UNSCEAR.  The letter, co-signed by 43 civil society groups from 9 countries, including 21 Japanese groups, requested revision of the 2014 UNSCEAR report on Fukushima accident as well as a new UN mandate for UNSCEAR.

Date: 24 October 2014
To: Members of the Fourth Committee of the UN General Assembly 69th Session, Members of UNSCEAR, and Members of the UN General Assembly:

Re:Civil Society groups request revision of the recent United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) Report: “Levels and effects of radiation exposure due to the nuclear accident after the 2011 Great East-Japan Earthquake and tsunami.”

The 2011 Fukushima disaster made UN oversight of the adverse effects of …

Fukushima Thyroid Examination May 2015: 103 Thyroid Cancer Cases Confirmed, 5 in the Second Round Screening

The Nineteenth Prefectural Oversight Committee for Fukushima Health Management Survey convened in Fukushima City, Fukushima Prefecture, on May 18, 2015, releasing the latest results of thyroid examination, consisting of Initial Screening or the first round screening (originally scheduled to be conducted from October 2011 to March 2014, but actually still ongoing) and Full-Scale Screening or the second round screening (beginning April 2014). It has been 3 months since the last committee meeting on February 12, 2015, and the latest results include 3 more months worth of data confirmed as of March 31, 2015.

An official English translation of the results is now available here.

As of March 31, 2015, there are 16 more (12 from the first round and 4 from the second round) confirmed cancer cases, all papillary thyroid cancer, and 9 more (2 from the first round and 7 from the second round) newly suspicious cases. The number of confirmed cancer cases now totals 103 (98 from the first round and 5…